| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $0.5B | $0.6B | $0.7B | $0.6B | $0.6B | $0.5B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $-0.0B | $0.0B | $-0.0B | $0.0B | $-0.1B | $-0.0B |
| EPS (Basic) | $3.14 | $1.84 | $-0.09 | $2.00 | $-1.48 | $4.93 | $-4.02 | $-0.55 |
| EPS (Diluted) | $3.12 | $1.83 | $-0.09 | $1.97 | $0.07 | $2.02 | $-5.20 | $-1.33 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B | $1.7B | $1.8B | $2.0B | $1.9B | $2.1B | $2.0B | $2.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B |
| Total Liabilities | $1.0B | $1.1B | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B | $1.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.7B | $0.6B | $0.6B | $0.7B | $0.7B | $0.7B | $0.6B | $0.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | — |
| Investing Cash Flow | $-0.0B | $-0.0B | $0.1B | $-0.1B | $0.2B | $-0.1B | $0.0B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.0B | $-0.0B | $-0.2B | $-0.0B | $-0.2B | $-0.0B | $-0.0B | — |